| scholarly article | Q13442814 |
| P2093 | author name string | G H Cohen | |
| R J Eisenberg | |||
| C Peng | |||
| R Tal-Singer | |||
| W R Abrams | |||
| F Tufaro | |||
| B W Banfield | |||
| M Ponce De Leon | |||
| P2860 | cites work | Inhibitory effect of heparin on herpes simplex virus | Q24646207 |
| Construction and properties of a mutant of herpes simplex virus type 1 with glycoprotein H coding sequences deleted | Q24655638 | ||
| Activity of herpes simplex virus type 1-specified glycoprotein C antigenic site II epitopes reversibly modulated by peripheral fucose or galactose units of glycoprotein oligosaccharides | Q28323282 | ||
| Identification of functional regions of herpes simplex virus glycoprotein gD by using linker-insertion mutagenesis | Q30416754 | ||
| A novel herpes simplex virus glycoprotein, gL, forms a complex with glycoprotein H (gH) and affects normal folding and surface expression of gH | Q33931805 | ||
| Anti-glycoprotein D antibodies that permit adsorption but block infection by herpes simplex virus 1 prevent virion-cell fusion at the cell surface | Q34335593 | ||
| Carbohydrates in herpesvirus infections | Q35232808 | ||
| A heterologous heparin-binding domain can promote functional attachment of a pseudorabies virus gC mutant to cell surfaces. | Q35831618 | ||
| Sequential isolation of proteoglycan synthesis mutants by using herpes simplex virus as a selective agent: evidence for a proteoglycan-independent virus entry pathway. | Q35839400 | ||
| Membrane proteins specified by herpes simplex viruses. III. Role of glycoprotein VP7(B2) in virion infectivity | Q36495307 | ||
| Proteins specified by herpes simplex virus. V. Purification and structural proteins of the herpesvirion | Q36503262 | ||
| Cell surface receptors for herpes simplex virus are heparan sulfate proteoglycans | Q36531041 | ||
| High-level expression and purification of secreted forms of herpes simplex virus type 1 glycoprotein gD synthesized by baculovirus-infected insect cells. | Q36626607 | ||
| The amino-terminal one-third of pseudorabies virus glycoprotein gIII contains a functional attachment domain, but this domain is not required for the efficient penetration of Vero cells. | Q36645344 | ||
| Glycoprotein C of herpes simplex virus type 1 plays a principal role in the adsorption of virus to cells and in infectivity | Q36681404 | ||
| Bovine herpesvirus 1 attachment to permissive cells is mediated by its major glycoproteins gI, gIII, and gIV | Q36681521 | ||
| A mutant herpes simplex virus type 1 unable to express glycoprotein L cannot enter cells, and its particles lack glycoprotein H | Q36686818 | ||
| Structural basis of C3b binding by glycoprotein C of herpes simplex virus | Q36698675 | ||
| Genetic analysis of type-specific antigenic determinants of herpes simplex virus glycoprotein C. | Q36700361 | ||
| Initial interaction of herpes simplex virus with cells is binding to heparan sulfate | Q36779935 | ||
| Fusion of intra- and extracellular forms of vaccinia virus with the cell membrane | Q36784043 | ||
| Absence of asparagine-linked oligosaccharides from glycoprotein D of herpes simplex virus type 1 results in a structurally altered but biologically active protein | Q36797418 | ||
| Characterization of a recombinant herpes simplex virus which expresses a glycoprotein D lacking asparagine-linked oligosaccharides | Q36797424 | ||
| Interaction of glycoprotein gIII with a cellular heparinlike substance mediates adsorption of pseudorabies virus | Q36799311 | ||
| Identification of C3b-binding regions on herpes simplex virus type 2 glycoprotein C | Q36804841 | ||
| Soluble forms of herpes simplex virus glycoprotein D bind to a limited number of cell surface receptors and inhibit virus entry into cells | Q36806734 | ||
| Entry of herpes simplex virus 1 in BJ cells that constitutively express viral glycoprotein D is by endocytosis and results in degradation of the virus | Q36825917 | ||
| Fine mapping of antigenic site II of herpes simplex virus glycoprotein D | Q36827612 | ||
| Neutralizing antibodies specific for glycoprotein H of herpes simplex virus permit viral attachment to cells but prevent penetration | Q36829924 | ||
| Pathogenicity in mice of herpes simplex virus type 2 mutants unable to express glycoprotein C | Q36860736 | ||
| Molecular basis of the glycoprotein C-negative phenotypes of herpes simplex virus type 1 mutants selected with a virus-neutralizing monoclonal antibody | Q36861859 | ||
| Putative glycoprotein gene of varicella-zoster virus with variable copy numbers of a 42-base-pair repeat sequence has homology to herpes simplex virus glycoprotein C | Q36867482 | ||
| Herpes simplex viruses lacking glycoprotein D are unable to inhibit virus penetration: quantitative evidence for virus-specific cell surface receptors | Q36873841 | ||
| Role of glycoprotein B of herpes simplex virus type 1 in viral entry and cell fusion | Q36877928 | ||
| Characterization of an equine herpesvirus type 1 gene encoding a glycoprotein (gp13) with homology to herpes simplex virus glycoprotein C. | Q36878840 | ||
| C3b receptor activity on transfected cells expressing glycoprotein C of herpes simplex virus types 1 and 2. | Q36881431 | ||
| Localization of discontinuous epitopes of herpes simplex virus glycoprotein D: use of a nondenaturing ("native" gel) system of polyacrylamide gel electrophoresis coupled with Western blotting | Q36883752 | ||
| Herpes simplex virus type 1 glycoprotein C-negative mutants exhibit multiple phenotypes, including secretion of truncated glycoproteins | Q36895826 | ||
| Characterization of the gene encoding herpes simplex virus type 2 glycoprotein C and comparison with the type 1 counterpart | Q36898146 | ||
| Specificities of monoclonal and polyclonal antibodies that inhibit adsorption of herpes simplex virus to cells and lack of inhibition by potent neutralizing antibodies. | Q36903438 | ||
| Epitopes of herpes simplex virus type 1 glycoprotein gC are clustered in two distinct antigenic sites | Q36903869 | ||
| Localization and synthesis of an antigenic determinant of herpes simplex virus glycoprotein D that stimulates the production of neutralizing antibody | Q36910738 | ||
| Virus-specific glycoproteins associated with the nuclear fraction of herpes simplex virus type 1-infected cells | Q36912380 | ||
| Mapping of the structural gene for the herpes simplex virus type 2 counterpart of herpes simplex virus type 1 glycoprotein C and identification of a type 2 mutant which does not express this glycoprotein | Q36912927 | ||
| Molecular basis of the glycoprotein-C-negative phenotype of herpes simplex virus type 1 macroplaque strain | Q36918662 | ||
| Detailed analysis of the portion of the herpes simplex virus type 1 genome encoding glycoprotein C | Q36930169 | ||
| Antigenic variants of herpes simplex virus selected with glycoprotein-specific monoclonal antibodies | Q36930264 | ||
| Fc and C3 receptors induced by herpes simplex virus on cultured human endothelial cells | Q37014056 | ||
| Infection of polarized MDCK cells with herpes simplex virus 1: two asymmetrically distributed cell receptors interact with different viral proteins | Q37530131 | ||
| Why are proteins O-glycosylated? | Q37951273 | ||
| Herpes simplex virus glycoprotein D acquires mannose 6-phosphate residues and binds to mannose 6-phosphate receptors. | Q38307003 | ||
| Antigenic and functional analysis of a neutralization site of HSV-1 glycoprotein D. | Q38342152 | ||
| Complement component C3b binds directly to purified glycoprotein C of herpes simplex virus types 1 and 2. | Q38348319 | ||
| Demonstration and mapping of highly carbohydrate-dependent epitopes in the herpes simplex virus type 1-specified glycoprotein C. | Q38349769 | ||
| Glycoprotein C of herpes simplex virus type 1: characterization of O-linked oligosaccharides | Q38354299 | ||
| Virus receptors: binding, adhesion strengthening, and changes in viral structure. | Q40037677 | ||
| Glycoprotein gB (gII) of pseudorabies virus can functionally substitute for glycoprotein gB in herpes simplex virus type 1. | Q40037944 | ||
| Analysis of the contributions of herpes simplex virus type 1 membrane proteins to the induction of cell-cell fusion | Q40042646 | ||
| Herpes simplex virus infection and propagation in a mouse L cell mutant lacking heparan sulfate proteoglycans | Q40043420 | ||
| Association of ICP0 but not ICP27 with purified virions of herpes simplex virus type 1 | Q40065211 | ||
| Herpes simplex virus type 1 entry through a cascade of virus-cell interactions requires different roles of gD and gH in penetration | Q40066951 | ||
| Identification of herpes simplex virus type 1 glycoproteins interacting with the cell surface | Q40109046 | ||
| Sialylated oligosaccharides O-glycosidically linked to glycoprotein C from herpes simplex virus type 1. | Q40124350 | ||
| Characterization of a pseudorabies virus glycoprotein gene with homology to herpes simplex virus type 1 and type 2 glycoprotein C. | Q40126375 | ||
| Interaction of viruses with cell surface receptors. | Q40133003 | ||
| Identification of structural features of heparin required for inhibition of herpes simplex virus type 1 binding | Q41372532 | ||
| Neomycin inhibits glycoprotein C (gC)-dependent binding of herpes simplex virus type 1 to cells and also inhibits postbinding events in entry | Q41448644 | ||
| Localization of a functional site on herpes simplex virus type 1 glycoprotein C involved in binding to cell surface heparan sulphate | Q41479052 | ||
| Cell-specific kinetics and efficiency of herpes simplex virus type 1 entry are determined by two distinct phases of attachment | Q41489513 | ||
| A peptide-model for the heparin-binding property of pseudorabies virus glycoprotein III. | Q41512378 | ||
| Herpes simplex virus glycoprotein C is a receptor for complement component iC3b | Q41664560 | ||
| Enhanced secretion from insect cells of a foreign protein fused to the honeybee melittin signal peptide | Q41695196 | ||
| Involvement of glycoprotein C (gC) in adsorption of herpes simplex virus type 1 (HSV-1) to the cell | Q41708907 | ||
| Effect of polylysine on the early stages of infection of wild type pseudorabies virus and of mutants defective in gIII. | Q41716587 | ||
| Glycoprotein C-dependent attachment of herpes simplex virus to susceptible cells leading to productive infection | Q41723305 | ||
| Structure of O-glycosidically linked oligosaccharides synthesized by the insect cell line Sf9. | Q41736215 | ||
| Penetration of cells by herpes simplex virus does not require a low pH-dependent endocytic pathway | Q41942419 | ||
| BHV-1 adsorption is mediated by the interaction of glycoprotein gIII with heparinlike moiety on the cell surface | Q42101846 | ||
| Glycoproteins gIII and gp50 play dominant roles in the biphasic attachment of pseudorabies virus. | Q42507901 | ||
| The interaction of glycoprotein C of herpes simplex virus types 1 and 2 with the alternative complement pathway | Q44018412 | ||
| Nucleotide sequence of the Marek's disease virus (MDV) RB-1B A antigen gene and the identification of the MDV A antigen as the herpes simplex virus-1 glycoprotein C homologue | Q44372651 | ||
| Glycoprotein C-independent binding of herpes simplex virus to cells requires cell surface heparan sulphate and glycoprotein B. | Q45230934 | ||
| Mapping of Heparin-Binding Structures on Bovine Herpesvirus 1 and Pseudorabies Virus gIII Glycoproteins | Q45786975 | ||
| Glycoprotein C of herpes simplex virus 1 acts as a receptor for the C3b complement component on infected cells | Q45796492 | ||
| A virion-associated glycoprotein essential for infectivity of herpes simplex virus type 1 | Q45801283 | ||
| Virus Infection of Endothelial Cells | Q45802359 | ||
| Herpes simplex virus glycoproteins associated with different morphological entities projecting from the virion envelope | Q45835285 | ||
| Glycoprotein gIII deletion mutants of pseudorabies virus are impaired in virus entry | Q45845502 | ||
| The different interactions of a gIII mutant of pseudorabies virus with several different cell types | Q45878400 | ||
| Nucleotide sequence of bovine herpesvirus type 1 glycoprotein gIII, a structural model for gIII as a new member of the immunoglobulin superfamily, and implications for the homologous glycoproteins of other herpesviruses | Q48283552 | ||
| Molecular modeling of protein-glycosaminoglycan interactions. | Q52546742 | ||
| Phylogeny of the third component of complement, C3: Analysis of the conservation of human CR1, CR2, H, and B binding sites, concanavalin A binding sites, and thiolester bond in the C3 from different species | Q58524723 | ||
| Evidence for multiple sites of interaction in C3 for complement receptor type 2 (C3d/EBV receptor, CD21) | Q67903950 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 4471-4483 | |
| P577 | publication date | 1995-07-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Interaction of herpes simplex virus glycoprotein gC with mammalian cell surface molecules | |
| P478 | volume | 69 |
| Q35914367 | A Dual-Modality Herpes Simplex Virus 2 Vaccine for Preventing Genital Herpes by Using Glycoprotein C and D Subunit Antigens To Induce Potent Antibody Responses and Adenovirus Vectors Containing Capsid and Tegument Proteins as T Cell Immunogens |
| Q38944967 | A Novel Thyroid Hormone Mediated Regulation of HSV-1 Gene Expression and Replication is Specific to Neuronal Cells and Associated with Disruption of Chromatin Condensation |
| Q33640201 | A gammaherpesvirus complement regulatory protein promotes initiation of infection by activation of protein kinase Akt/PKB. |
| Q34281238 | Amino acid differences in glycoproteins B (gB), C (gC), H (gH) and L (gL) are associated with enhanced herpes simplex virus type-1 (McKrae) entry via the paired immunoglobulin-like type-2 receptor α. |
| Q34552933 | An external loop region of domain III of dengue virus type 2 envelope protein is involved in serotype-specific binding to mosquito but not mammalian cells |
| Q40723465 | Analysis of herpes simplex virus entering into cells of oral origin |
| Q34237174 | Antibody-induced conformational changes in herpes simplex virus glycoprotein gD reveal new targets for virus neutralization |
| Q38532388 | Antibody-mediated targeted gene transfer of helper virus-free HSV-1 vectors to rat neocortical neurons that contain either NMDA receptor 2B or 2A subunits |
| Q39685068 | Antibody-mediated targeted gene transfer to NMDA NR1-containing neurons in rat neocortex by helper virus-free HSV-1 vector particles containing a chimeric HSV-1 glycoprotein C-staphylococcus A protein |
| Q35880763 | Antigenic structure of soluble herpes simplex virus (HSV) glycoprotein D correlates with inhibition of HSV infection |
| Q40923636 | Antiherpetic activity and mode of action of natural carrageenans of diverse structural types |
| Q37060288 | Blocking Immune Evasion as a Novel Approach for Prevention and Treatment of Herpes Simplex Virus Infection |
| Q24646778 | Blocking antibody access to neutralizing domains on glycoproteins involved in entry as a novel mechanism of immune evasion by herpes simplex virus type 1 glycoproteins C and E |
| Q34057952 | Blocking herpes simplex virus 2 glycoprotein E immune evasion as an approach to enhance efficacy of a trivalent subunit antigen vaccine for genital herpes |
| Q40642196 | Carboxy-fluorescein diacetate, succinimidyl ester labeled papillomavirus virus-like particles fluoresce after internalization and interact with heparan sulfate for binding and entry. |
| Q38295126 | Cell surface heparan sulfate is a receptor for human herpesvirus 8 and interacts with envelope glycoprotein K8.1. |
| Q33785040 | Cell surface proteoglycans are necessary for A27L protein-mediated cell fusion: identification of the N-terminal region of A27L protein as the glycosaminoglycan-binding domain. |
| Q42063269 | Characterization of canine herpesvirus glycoprotein C expressed by a recombinant baculovirus in insect cells |
| Q92117474 | Characterization of feline herpesvirus-1 deletion mutants in tissue explant cultures |
| Q35316002 | Clinical and epidemiological features of acute follicular conjunctivitis with special reference to that caused by herpes simplex virus type 1. |
| Q90126817 | Coagulation factor VIIa binds to herpes simplex virus 1-encoded glycoprotein C forming a factor X-enhanced tenase complex oriented on membranes |
| Q35176375 | Complement: structure, functions, evolution, and viral molecular mimicry |
| Q33837131 | Design and application of HSV vectors for neuroprotection |
| Q39874536 | Differences in the susceptibility of herpes simplex virus types 1 and 2 to modified heparin compounds suggest serotype differences in viral entry |
| Q45710613 | Direct Binding of Herpes Simplex Virus Type 1 Virions to Complement C3 |
| Q34593833 | Dissection of the antibody response against herpes simplex virus glycoproteins in naturally infected humans |
| Q35866354 | Disulfide bond structure determination and biochemical analysis of glycoprotein C from herpes simplex virus |
| Q34382530 | Dysregulation of autophagy in murine fibroblasts resistant to HSV-1 infection |
| Q33327584 | Enhanced nigrostriatal neuron-specific, long-term expression by using neural-specific promoters in combination with targeted gene transfer by modified helper virus-free HSV-1 vector particles |
| Q34435088 | Epitope mapping of herpes simplex virus type 2 gH/gL defines distinct antigenic sites, including some associated with biological function |
| Q33783757 | Functional region IV of glycoprotein D from herpes simplex virus modulates glycoprotein binding to the herpesvirus entry mediator |
| Q44216103 | Glycoprotein C plays a role in the adsorption of duck enteritis virus to chicken embryo fibroblasts cells and in infectivity |
| Q35890209 | Glycoprotein D of herpes simplex virus (HSV) binds directly to HVEM, a member of the tumor necrosis factor receptor superfamily and a mediator of HSV entry |
| Q36134871 | HSV trafficking and development of gene therapy vectors with applications in the nervous system |
| Q40688129 | HSV-1 amplicon peptide display vector |
| Q36925941 | HSV-1 exploits the innate immune scavenger receptor MARCO to enhance epithelial adsorption and infection. |
| Q40581107 | HSV-1 virions engineered for specific binding to cell surface receptors |
| Q33785801 | Heparan sulfate proteoglycan binding by herpes simplex virus type 1 glycoproteins B and C, which differ in their contributions to virus attachment, penetration, and cell-to-cell spread |
| Q27485008 | Herpes Simplex Virus Type 2 Glycoprotein G Is Targeted by the Sulfated Oligo- and Polysaccharide Inhibitors of Virus Attachment to Cells |
| Q33987520 | Herpes simplex virus glycoprotein B binds to cell surfaces independently of heparan sulfate and blocks virus entry |
| Q36324514 | Herpes simplex virus triggers activation of calcium-signaling pathways |
| Q33843108 | Herpes simplex virus type 1 enters human epidermal keratinocytes, but not neurons, via a pH-dependent endocytic pathway |
| Q34092761 | Herpes simplex virus type 1 glycoprotein e is required for axonal localization of capsid, tegument, and membrane glycoproteins |
| Q33784923 | Herpes simplex virus type 1 glycoprotein gC mediates immune evasion in vivo |
| Q34070145 | Herpes simplex virus type 1-based amplicon vector systems |
| Q41873760 | Herpes simplex virus type 1-encoded glycoprotein C contributes to direct coagulation factor X-virus binding |
| Q39539848 | Herpes simplex virus types 1 and 2 differ in their interaction with heparan sulfate. |
| Q34344174 | Herpesviruses and heparan sulfate: an intimate relationship in aid of viral entry |
| Q45731304 | High level expression and secretion of truncated forms of herpes simplex virus type 1 and type 2 glycoprotein D by the methylotrophic yeast Pichia pastoris |
| Q39736541 | Human antibodies to herpes simplex virus type 1 glycoprotein C are neutralizing and target the heparan sulfate-binding domain |
| Q39591011 | Identification and analysis of a novel heparin-binding glycoprotein encoded by human herpesvirus 7. |
| Q41253220 | Identification and characterization of duck plague virus glycoprotein C gene and gene product |
| Q35863299 | Immune evasion properties of herpes simplex virus type 1 glycoprotein gC. |
| Q37392882 | Immune responses to herpesviral vectors |
| Q36955074 | Immunization strategies to block the herpes simplex virus type 1 immunoglobulin G Fc receptor |
| Q37439603 | Immunization with HSV-1 glycoprotein C prevents immune evasion from complement and enhances the efficacy of an HSV-1 glycoprotein D subunit vaccine |
| Q35275146 | Immunization with a vaccine combining herpes simplex virus 2 (HSV-2) glycoprotein C (gC) and gD subunits improves the protection of dorsal root ganglia in mice and reduces the frequency of recurrent vaginal shedding of HSV-2 DNA in guinea pigs compa |
| Q45453302 | Implications for herpes simplex virus vaccine strategies based on antibodies produced to herpes simplex virus type 1 glycoprotein gC immune evasion domains |
| Q36375668 | In vivo role of complement-interacting domains of herpes simplex virus type 1 glycoprotein gC |
| Q35867958 | Live attenuated herpes simplex virus 2 glycoprotein E deletion mutant as a vaccine candidate defective in neuronal spread |
| Q35382962 | Low-pH-dependent changes in the conformation and oligomeric state of the prefusion form of herpes simplex virus glycoprotein B are separable from fusion activity |
| Q37644037 | Mechanism of neutralization of herpes simplex virus by antibodies directed at the fusion domain of glycoprotein B. |
| Q38077470 | Members of 3-O-Sulfotransferases (3-OST) Family: A Valuable Tool from Zebrafish to Humans for Understanding Herpes Simplex Virus Entry |
| Q39610129 | Modified FGF4 signal peptide inhibits entry of herpes simplex virus type 1. |
| Q38300374 | Molecular basis for resistance of herpes simplex virus type 1 mutants to the sulfated oligosaccharide inhibitor PI-88. |
| Q33782593 | Monoclonal antibodies to distinct sites on herpes simplex virus (HSV) glycoprotein D block HSV binding to HVEM |
| Q38854789 | Mucin-like Region of Herpes Simplex Virus Type 1 Attachment Protein Glycoprotein C (gC) Modulates the Virus-Glycosaminoglycan Interaction |
| Q90196797 | Nucleoside-modified mRNA encoding HSV-2 glycoproteins C, D, and E prevents clinical and subclinical genital herpes |
| Q35973512 | Patient-Specific Neutralizing Antibody Responses to Herpes Simplex Virus Are Attributed to Epitopes on gD, gB, or Both and Can Be Type Specific |
| Q42176895 | Phylogenetic comparison of exonic US4, US7 and UL44 regions of clinical herpes simplex virus type 1 isolates showed lack of association between their anatomic sites of infection and genotypic/sub genotypic classification |
| Q45428810 | Physical and immunological characterization of a recombinant secreted form of the membrane protein encoded by the vaccinia virus L1R gene |
| Q40304907 | Porcine circovirus 2 uses heparan sulfate and chondroitin sulfate B glycosaminoglycans as receptors for its attachment to host cells |
| Q39292256 | Postentry events are responsible for restriction of productive varicella-zoster virus infection in Chinese hamster ovary cells |
| Q37547107 | Protection provided by a herpes simplex virus 2 (HSV-2) glycoprotein C and D subunit antigen vaccine against genital HSV-2 infection in HSV-1-seropositive guinea pigs |
| Q33799437 | Pseudotyping of glycoprotein D-deficient herpes simplex virus type 1 with vesicular stomatitis virus glycoprotein G enables mutant virus attachment and entry |
| Q39577652 | Receptor-binding properties of a soluble form of human cytomegalovirus glycoprotein B. |
| Q37415391 | Regulation of HSV glycoprotein induced cascade of events governing cell-cell fusion |
| Q33883878 | Regulation of herpes simplex virus type 1 thymidine kinase gene expression by thyroid hormone receptor in cultured neuronal cells |
| Q33900262 | Repertoire of epitopes recognized by serum IgG from humans vaccinated with herpes simplex virus 2 glycoprotein D |
| Q39602751 | Requirement of interaction of nectin-1alpha/HveC with afadin for efficient cell-cell spread of herpes simplex virus type 1. |
| Q100295191 | Role of cholesterol in anatid herpesvirus 1 infections in vitro |
| Q90458456 | Saliva enhances infection of gingival fibroblasts by herpes simplex virus 1 |
| Q35653504 | Sequence analysis of the 5' third of glycoprotein C gene of South American bovine herpesviruses 1 and 5. |
| Q35877278 | Specificity and affinity of binding of herpes simplex virus type 2 glycoprotein B to glycosaminoglycans |
| Q34546016 | Stable association of herpes simplex virus with target membranes is triggered by low pH in the presence of the gD receptor, HVEM |
| Q41710756 | Structure, functions, and evolution of the third complement component and viral molecular mimicry |
| Q24538731 | Structure-based analysis of the herpes simplex virus glycoprotein D binding site present on herpesvirus entry mediator HveA (HVEM). |
| Q35020198 | Structure-function analysis of herpes simplex virus type 1 gD and gH-gL: clues from gDgH chimeras |
| Q35861628 | Structure-function analysis of soluble forms of herpes simplex virus glycoprotein D. |
| Q92512520 | Successful application of prime and pull strategy for a therapeutic HSV vaccine |
| Q59813042 | Sulfotransferase and Heparanase: Remodeling Engines in Promoting Virus Infection and Disease Development |
| Q40402866 | Targeted gene transfer to nigrostriatal neurons in the rat brain by helper virus-free HSV-1 vector particles that contain either a chimeric HSV-1 glycoprotein C-GDNF or a gC-BDNF protein |
| Q34073330 | Targeting HSV-1 virions for specific binding to epidermal growth factor receptor-vIII-bearing tumor cells |
| Q91962784 | Targeting STT3A-oligosaccharyltransferase with NGI-1 causes herpes simplex virus 1 dysfunction |
| Q45888950 | Targeting human glioma cells using HSV-1 amplicon peptide display vector. |
| Q42642478 | The Importance of Heparan Sulfate in Herpesvirus Infection |
| Q33781867 | The gH-gL complex of herpes simplex virus (HSV) stimulates neutralizing antibody and protects mice against HSV type 1 challenge |
| Q38206635 | The procoagulant envelope virus surface: contribution to enhanced infection |
| Q35855824 | The receptor-binding domain of pseudorabies virus glycoprotein gC is composed of multiple discrete units that are functionally redundant |
| Q41035870 | The varicella zoster virus glycoprotein B (gB) plays a role in virus binding to cell surface heparan sulfate proteoglycans |
| Q39715541 | Thyroid hormone controls the gene expression of HSV-1 LAT and ICP0 in neuronal cells. |
| Q38961062 | Thyroid hormone-dependent epigenetic suppression of herpes simplex virus-1 gene expression and viral replication in differentiated neuroendocrine cells |
| Q35531731 | Update on emerging antivirals for the management of herpes simplex virus infections: a patenting perspective |
| Q36304909 | Using a split luciferase assay (SLA) to measure the kinetics of cell-cell fusion mediated by herpes simplex virus glycoproteins |
| Q27488704 | Vaccinia virus L1 binds to cell surfaces and blocks virus entry independently of glycosaminoglycans |
Search more.